Sinoma Science & Technology Co.,Ltd.

SZSE:002080 Lagerbericht

Marktkapitalisierung: CN¥22.0b

Sinoma Science & TechnologyLtd Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Sinoma Science & TechnologyLtd wird ein jährliches Gewinn- und Umsatzwachstum von 33.7% bzw. 14.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 33.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 8.9% betragen.

Wichtige Informationen

33.7%

Wachstumsrate der Gewinne

33.7%

EPS-Wachstumsrate

Chemicals Gewinnwachstum39.4%
Wachstumsrate der Einnahmen14.4%
Zukünftige Eigenkapitalrendite8.9%
Analystenabdeckung

Good

Zuletzt aktualisiert01 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Nov 04
Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Oct 08
Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Sep 25
Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Sep 10
Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Aug 26
Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

Aug 21
Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Jul 25
These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Jun 10
Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

May 27
Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

May 13
Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Apr 14
Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Mar 31
Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Mar 14
Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Feb 28
Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Gewinn- und Umsatzwachstumsprognosen

SZSE:002080 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202632,8022,2139256,0089
12/31/202529,3171,801-6174,55810
12/31/202423,8051,048-1,6194,9445
9/30/202424,3881,1261596,434N/A
6/30/202424,0501,298-3,1524,436N/A
3/31/202425,2762,027-3,8064,305N/A
12/31/202325,8892,224-2,9454,820N/A
9/30/202326,3172,836-5,1462,289N/A
6/30/202326,7573,079-3,6233,021N/A
3/31/202326,1963,253-2,2903,227N/A
1/1/202325,8143,574-1,6323,031N/A
9/30/202223,4623,1722053,415N/A
6/30/202222,3723,4136972,984N/A
3/31/202220,9343,5186032,352N/A
12/31/202120,2953,3731,8693,672N/A
9/30/202120,5223,1591,4823,255N/A
6/30/202120,6002,9771,6643,800N/A
3/31/202119,9992,3875162,986N/A
12/31/202018,8652,0405603,273N/A
9/30/202017,0381,8892343,295N/A
6/30/202015,1481,6341483,084N/A
3/31/202013,8211,4051,1793,557N/A
12/31/201913,5901,3807932,970N/A
9/30/201913,1481,1671572,021N/A
6/30/201912,7321,165-1531,621N/A
3/31/201911,985962-5741,378N/A
12/31/201811,411894-1471,564N/A
9/30/201810,807913-1,203630N/A
6/30/201810,504778N/A771N/A
3/31/201810,289778N/A654N/A
12/31/201710,237767N/A770N/A
9/30/20179,695699N/A1,622N/A
6/30/20179,386539N/A1,161N/A
3/31/20179,205499N/A1,118N/A
12/31/20168,700438N/A1,082N/A
9/30/20168,785436N/A858N/A
6/30/20168,813568N/A1,103N/A
3/31/20169,728678N/A861N/A
12/31/20159,176630N/A1,399N/A
9/30/20158,216613N/A654N/A
6/30/20156,989451N/A767N/A
3/31/20154,837194N/A944N/A
12/31/20144,424152N/A382N/A
9/30/20143,981108N/A601N/A
6/30/20143,68092N/A731N/A
3/31/20143,54596N/A88N/A
12/31/20133,443108N/A253N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 002080Das prognostizierte Gewinnwachstum (33.7% pro Jahr) liegt über der Sparquote (2.8%).

Ertrag vs. Markt: 002080Die Erträge des Unternehmens (33.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt CN (26.1% pro Jahr).

Hohe Wachstumserträge: 002080Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: 002080Die Einnahmen des Unternehmens (14.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt CN (13.9% pro Jahr).

Hohe Wachstumseinnahmen: 002080Die Einnahmen des Unternehmens (14.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 002080Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (8.9%).


Wachstumsunternehmen entdecken